Evropská unie - čeština - EMA (European Medicines Agency)

virbac s.a. - recombinant omega interferon of feline origin - immunostimulants, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. in cats infected by fiv, mortality was low (5%) and was not influenced by the treatment.

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

orpha-devel handels und vertriebs gmbh, purkersdorf array - 12957 argipressin-acetÁt - koncentrát pro infuzní roztok - 40iu/2ml - vasopressin (argipressin)

Evropská unie - čeština - EMA (European Medicines Agency)

novartis europharm limited - sacubitril, valsartan - srdeční selhání - antagonisté angiotensinu ii, jiné kombinace, látky působící na renin-angiotensinový systém - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.

Evropská unie - čeština - EMA (European Medicines Agency)

novartis europharm limited - sacubitril, valsartan - srdeční selhání - agens působící na systém renin-angiotenzin - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

merck spol. s r.o., praha array - 451 dexamethason - tableta - 4mg - dexamethason

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

hexal ag, holzkirchen array - 651 furosemid - tableta - 125mg - furosemid

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

hexal ag, holzkirchen array - 651 furosemid - tableta - 250mg - furosemid

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

hexal ag, holzkirchen array - 651 furosemid - tableta - 500mg - furosemid

Evropská unie - čeština - EMA (European Medicines Agency)

merck sharp & dohme b.v. - doravirine, lamivudin, tenofovir-disoproxyl-fumarát - hiv infekce - antivirotika pro léčbu infekcí hiv, kombinace - delstrigo je indikován k léčbě dospělých infikovaných hiv-1 bez minulosti nebo současnosti důkazy rezistence vůči nnrti třídy, lamivudin, nebo tenofovir. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.

Česká republika - čeština - USKVBL (Ústav Pro Státní Kontrolu Veterinárních Biopreparátů A Léčiv)

krka d.d. novo mesto - enrofloxacin - injekční roztok - 100mg/ml - fluorochinolony - skot, prasata